Gaurav Kaithwas-Gautam
Raebareli Road
Lucknow, UP 226025, India
Lucknow, UP 226025, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Repurposing mechanistic insight of PDE-5 inhibitor in cancer chemoprevention through mitochondrial-oxidative stress intervention and blockade of DuCLOX signalling.
Journal: BMC cancer
Published: February 11, 2019
Short communication: Evaluation of α-linolenic acid-based intramammary nanosuspension for treatment of subclinical mastitis.
Journal: Journal of dairy science
Published: January 02, 2019
PHD-2 activation: a novel strategy to control HIF-1α and mitochondrial stress to modulate mammary gland pathophysiology in ER+ subtype.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: November 15, 2018
Chemical activation of prolyl hydroxylase-2 by BBAP-1 down regulates hypoxia inducible factor-1α and fatty acid synthase for mammary gland chemoprevention.
Journal: RSC advances
Published: February 08, 2018
Effects of phenidone (DuCLOX-2/5 inhibitor) against N-methyl-N-nitrosourea induced mammary gland carcinoma in albino rats.
Journal: Toxicology and applied pharmacology
Published: December 16, 2017
Effect of early natal supplementation of paracetamol on attenuation of exotoxin/endotoxin induced pyrexia and precipitation of autistic like features in albino rats.
Journal: Inflammopharmacology
Published: June 30, 2017
Galantamine attenuates N,N-dimethyl hydrazine induced neoplastic colon damage by inhibiting acetylcholinesterase and bimodal regulation of nicotinic cholinergic neurotransmission.
Journal: European journal of pharmacology
Published: June 27, 2017
α-Chymotrypsin regulates free fatty acids and UCHL-1 to ameliorate N-methyl nitrosourea induced mammary gland carcinoma in albino wistar rats.
Journal: Inflammopharmacology
Published: June 21, 2016
DuCLOX-2/5 inhibition: a promising target for cancer chemoprevention.
Journal: Breast cancer (Tokyo, Japan)
Published: June 15, 2016
Redefining the role of peripheral LPS as a neuroinflammatory agent and evaluating the role of hydrogen sulphide through metformin intervention.
Journal: Inflammopharmacology
Published: June 14, 2016
Last Updated: 09/26/2026